Items Tagged ‘#Biomanufacturing’
November 11, 2021
Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021 recap
“The future of regenerative medicine is bright,” declared Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, as she delivered the opening keynote address of the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021. Dr. Allickson is the Otto Bremer Trust Director, Biomanufacturing and Product […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Dr. Peter Marks, #Dr. Richard Gray, #Dr. Richard Hayden, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
November 4, 2021
Mayo Clinic poised to biomanufacture a new era of biotherapeutics
ROCHESTER, Minn. — Mayo Clinic has launched a new biomanufacturing strategy that seeks to develop next-generation biotherapeutics that go beyond standard pharmaceuticals and deliver new cures for rare and complex conditions. The opportunities and challenges in this emerging field will be showcased at the Mayo Clinic Symposium on Regenerative Medicine & Surgery 2021, which will […]
Tags: #Biomanufacturing, #biotherapeutics, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
October 14, 2021
Overcoming regulatory challenges to licensing new biotherapeutics
Mayo Clinic’s Symposium on Regenerative Medicine and Surgery will explore the challenges and opportunities of bringing next-generation biotherapeutics to patients. Julie Allickson, Ph.D., the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine, will deliver a keynote presentation addressing regulatory hurdles standing between the billions of dollars invested in regenerative […]
Tags: #Biomanufacturing, #Dr. Atta Behfar, #Dr. Julie Allickson, #Dr. Peter Marks, #Dr. Richard Hayden, #Dr. Todd Rasmussen, #Dr. William Faubion, #FDA, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Symposium on Regenerative Medicine and Surgery
September 16, 2021
A robotic GPS for targeting, delivering regenerative biotherapies
A remote-controlled bronchoscope that acts like a GPS system hunts down hard to find lung masses and accurately biopsies them, according to a Mayo Clinic collaborative study. This multisite research, which is published in Annals of Thoracic Surgery, lays the foundation for precisely finding early stage cancer and targeting it with regenerative biotherapeutics needed to […]
Tags: #Biomanufacturing, #biotherapeutics, #bronchoscope, #Dr. Janani Reisenauer, #lung cancer, #Mayo Clinic Center for Regenerative Medicine, Dr. Julie Allickson
August 19, 2021
A new understanding of the inner workings of CAR-T cell therapy
Mayo Clinic researchers have biomanufactured chimeric antigen receptor-T cell therapy (CAR-T cell therapy) in a new way to track the cells’ cancer fighting journey and predict toxic side effects. This Mayo Clinic breakthrough, published in Cancer Immunology Research, also could unravel the mystery of how to unleash CAR-T cell therapy to destroy solid tumors. “This […]
Tags: #Biomanufacturing, #CAR-T cell therapy, #Dr. Saad Kenderian, #Mayo Clinic Center for Regenerative Medicine, #regenerative iimmunotherapies
June 4, 2021
New director named for Center for Regenerative Medicine
Julie Allickson, Ph.D., has been named the Michael S. and Mary Sue Shannon Director of Mayo Clinic’s Center for Regenerative Medicine and the Otto Bremer Trust Director, Biomanufacturing and Product Development, Center for Regenerative Medicine. Dr. Allickson joins Mayo Clinic from Wake Forest Institute for Regenerative Medicine at Wake Forest School of Medicine, where she […]
Tags: #Biomanufacturing, #Dr. Julie Allickson, #Mayo Clinic Center for Regenerative Medicine
February 1, 2021
Advancing cell-based regenerative therapy for heart failure
February is American Heart Month, a time to highlight innovative research that seeks to advance cellular therapy as a new option for restoring heart health. One of the latest discoveries in the Center for Regenerative Medicine and Mayo Clinic Van Cleve Cardiac Regenerative Medicine Program established a way to engineer stem cells that activate regenerative […]
Tags: #Atta Behfar, #Biomanufacturing, #Cardiac regeneration, #cardiopoietic cells, #Mark Li, #Mayo Clinic Alix School of Medicine, #Mayo Clinic Center for Regenerative Medicine, #Mayo Clinic Graduate School of Biomedical Sciences
January 14, 2021
Advancing regenerative care through biomanufacturing
One of the challenges of integrating regenerative medicine into patient care is the time and regulatory rigor it takes to validate new therapies. Mayo Clinic’s Center for Regenerative Medicine is working with industry collaborators to streamline the process of moving the latest tissue engineered and cellular products from bench to bedside. As part of its […]
Tags: #ARMI BioFabUSA, #Biomanufacturing, #Dr. Jorge Mallea, #Mayo Clinic Center for Regenerative Medicine, #Regenerative therapies, #Tissue engineering
May 7, 2020
A discovery step toward cell replacement therapy for diabetes
In what could be a step toward cell replacement therapy for diabetes, Mayo Clinic researchers have discovered how to manufacture cells capable of generating a hormone that regulates low blood sugar. Quinn Peterson, Ph.D. and his team have developed a new method of mass producing a cell product containing the hormone glucagon that is capable […]
Tags: #Biomanufacturing, #cell replacement therapy, #Diabetes, #Dr. Quinn Peterson, #hypoglycemia, #Mayo Clinic Center for Regenerative Medicine, #stem cells
April 23, 2020
Training the workforce of the future in CAR T-cell therapy
Mayo Clinic is equipping the next generation of physician-scientists with knowledge to bring chimeric antigenic receptor (CAR) T-cell therapy to more patients. One of the first medical centers to offer CAR T, Mayo Clinic is sharing its unique knowledge of this regenerative immunotherapy in a first-of-its kind graduate mini course offered through the Mayo Clinic […]
Tags: #Biomanufacturing, #CAR T-cell therapy, #Dr. Saad Kenderian, #Mayo Clinic Center for Regenerative Medicine